Chronic Kidney Disease
According to the FIDELIO-DKD trial, do you know finerenone’s impact on incidence of the composite cardiovascular outcome? Test your knowledge with our latest pop quiz!
What's the Take Home?
A 67-year-old man presented to the office for a general medical examination. He had no new or significant symptoms to report. Of particular interest, 16 years ago, abdominal ultrasonography for gastrointestinal tract reasons had shown an incidental 2.3-cm renal mass.
In a recent study, researchers investigated the effects of weight fluctuations in patients with chronic kidney disease on risk of cardiovascular-related outcomes and mortality.
James Matera, DO, discusses how lipid disorders impact the management of chronic kidney disease (CKD), and whether statins are safe for use in patients with comorbid lipid disorders and CKD.